Civamide cream 0.075% in patients with osteoarthritis of the knee: A 12-week randomized controlled clinical trial with a longterm extension

Journal of Rheumatology

Volumn 39, Issue 3, 2012, Pages 610-620

  Schnitzer, Thomas J ^a   Pelletier, Jean Pierre ^j   Haselwood, Doug M ^b   Ellison, William T ^c   Ervin, John E ^d   Gordon, Richard D ^e   Lisse, Jeffrey R ^f   Archambault, W Tad ^g   Sampson, Allan R ^h   Fezatte, Heidi B ⁱ   Phillips, Scott B ⁱ   Bernstein, Joel E ⁱ  

^a NORTHWESTERN UNIVERSITY   (United States)

^b Med Investigations   (United States)

^c RADIANT RESEARCH   (United States)

^d Center for Pharmaceutical Research   (United States)

^e Arthritis Regional Research Center   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g Virtu Stat Ltd   (United States)

^h UNIVERSITY OF PITTSBURGH   (United States)

ⁱ Winston Laboratories Inc   (United States)

^j CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

more..

Author keywords

Double blind study; Osteoarthritis; Phase 3; Topical administration; TRPV 1 receptor; Zucapsaicin

Indexed keywords

CIS CAPSAICIN;

ADULT; AGED; APPLICATION SITE ANESTHESIA; APPLICATION SITE BURNING; APPLICATION SITE IRRITATION; APPLICATION SITE PAIN; APPLICATION SITE PRURITUS; APPLICATION SITE RASH; APPLICATION SITE REACTION; APPLICATION SITE WARMTH; ARTHRALGIA; ARTICLE; BURNING SENSATION; CONTROLLED STUDY; COUGHING; DOUBLE BLIND PROCEDURE; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG INDUCED HEADACHE; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EYE IRRITATION; FEMALE; HUMAN; KNEE OSTEOARTHRITIS; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; OSTEOARTHRITIS; OSTEOARTHRITIS PAIN SCORE; PAIN ASSESSMENT; PATIENT COMPLIANCE; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; SCORING SYSTEM; SIDE EFFECT; SNEEZING; SUBJECT GLOBAL EVALUATION; WESTERN ONTARIO AND MCMASTER UNIVERSITIES INDEX;

ADMINISTRATION, TOPICAL; ADULT; AGED; CAPSAICIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; KNEE JOINT; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOARTHRITIS, KNEE; TIME FACTORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84857879305     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110192     Document Type: Article

References (31)

1. Jakobsson U, Hallberg IR. Quality of life among older adults with osteoarthritis: an explorative study. J Gerontol Nurs 2006;32:51-60.
2. EULAR recommendations for the treatment of osteoarthritis of the knee in general practice [CD ROM]. Princeton, NJ: Bristol-Myers Squibb/Laboratories UPSA; 2003.
3. Arthritis Research Campaign. Arthritis: The big picture. London: Arthritis Research Campaign; 2002.
4. Yaksh TL, Aimone LD. Final report: Examination of the effects of intrathecally administered synthetic and extracted capsaicin on the levels of SP, CBRP and VIP in the dorsal and ventral horns of the rat spinal cord. Research report. Laboratory of Anesthesiology Research, Department of Anesthesiology, University of California, San Diego: 1989. Report on file, Winston Laboratories Inc.
5. Yaksh TL. Effects of intrathecally administered galen capsaicinoid drugs on hotplate and spinal SP levels. Research report. Laboratory of Anesthesiology Research, Department of Anesthesiology, University of California, San Diego: 1990. Report on file, Winston Laboratories Inc.
6. McMahon SB, Lewin G, Bloom SR. The consequences of long-term topical capsaicin application in the rat. Pain 1991;44:301-10.
7. Valenzano KJ, Sun Q. Current perspectives on the therapeutic utility of VR1 antagonists. Curr Med Chem 2004;11:3185-202. (Pubitemid 39534745)
8. Story GM. The emerging role of TRP channels in mechanisms of temperature and pain sensation. Curr Neuropharmacol 2006;4:183-96.
9. Buck SH, Burks TF. The neuropharmacology of capsaicin: Review of some recent observations. Pharmacol Rev 1986;38:179-226. (Pubitemid 16031645)
10. Report on file, Study WL-1001-05-02. Vernon Hills, IL: Winston Laboratories Inc.
11. Reports on file, studies 1103-5651-01 and 1103-5651-03. Vernon Hills, IL: Winston Laboratories Inc.
12. Bernstein JE, Phillips SB, Birbara C, Khairi R. Osteoarthritis pain is relieved by topically applied civamide [abstract]. American Pain Society. Abstract on file, Winston Laboratories Inc.
13. Steinbrocker O, Traeger CH, Batterman RC. Therapeutic criteria in rheumatoid arthritis. JAMA 1949;140:659-62.
14. Bellamy N. WOMAC Osteoarthritis Index user guide. Version V. Brisbane, Australia: 2002.
15. Ware JE, Kosinski M, Dewey JE. How to score Version 2 of the SF-36 Health Survey. Lincoln, RI: Quality Metric Inc.; 2000.
16. Pham T, van der Heijde D, Altman RD, Anderson JJ, Bellamy N, Hochberg M, et al. OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. Osteoarthritis Cartilage 2004;12:389-99. (Pubitemid 38594267)
17. ICH Topic E 9: Statistical principles for clinical trials. European Medicines Agency: CPMP/ICH/363/96; 1998.
18. Breivik H, Borchgrevink PC, Allen SM, Rosseland LA, Romundstad L, Hals EK, et al. Assessment of pain. Br J Anaesth 2008;101:17-24. (Pubitemid 351881909)
19. Collins SL, Moore A, McQuay HJ. The visual analogue pain intensity scale: What is moderate pain in millimeters? Pain 1997;72:95-7. (Pubitemid 27321906)
20. Sriwatanakul K, Kelvie W, Lasagna L. The quantification of pain: An analysis of words used to describe pain and analgesia in clinical trials. Clin Pharmacol Ther 1982;32:143-8. (Pubitemid 13000951)
21. Silverfield JC, Kamin M, Wu S-C, Rosenthal N. Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: A multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther 2002;24:282-97. (Pubitemid 34208422)
22. Tugwell PS, Wells GA, Shainhouse JZ. Equivalence study of a topical diclofenac solution (Pennsaid®) compared with oral diclofenac in symptomatic treatment of osteoarthritis of the knee: A randomized controlled trial. J Rheumatol 2004;31:2002-12. (Pubitemid 39336727)
23. Simon LS, Grierson LM, Naseer Z, Bookman AAM, Shainhouse JZ. Efficacy and safety of topical diclofenac containing dimethyl sulfoxide (DMSO) compared with those of topical placebo, DMSO vehicle and oral diclofenac for knee osteoarthritis. Pain 2009;143:238-45.
24. Jordan KM, Arden NK, Doherty M, Bannwarth B, Bijlsma JW, Dieppe P, et al. EULAR Recommendations 2003: An evidence based approach to the management of knee osteoarthritis: Report of a Task Force of the Standing Committee for International Clinical Studies Including Therapeutic Trials (ESCISIT). Ann Rheum Dis 2003;62:1145-55. (Pubitemid 37500619)
25. Griffin MR, Ray WA, Schaffner W. Nonsteroidal anti-inflammatory drug use and death from peptic ulcer in elderly persons. Ann Intern Med 1988;108:359-63.
26. Voltaren® gel (diclofenac sodium topical gel) label warning for cardiovascular and gastrointestinal risk: Sept 22, 2009. [Internet. Accessed Oct 27, 2011.] Available from: http://www.voltarengel.com/ common/pdf/Voltaren-PI- 10-19.pdf
27. Pennsaid® (diclofenac sodium topical solution) 1.5% label warning for cardiovascular and gastrointestinal risk: March 25, 2010. [Internet: Accessed Oct 27, 2011.] Available from: http://pharmaceuticals. covidien.com/imageServer. aspx/doc196231.pdf?contentID=17143 &contenttype=application/pdf
28. Deal CL, Schnitzer TJ, Lipstein E, Seibold JR, Stevens RM, Levy MD, et al. Treatment of arthritis with topical capsaicin: A double-blind trial. Clin Ther 1991;13:383-95.
29. Altman RD, Aven A, Holmburg CE, Pfeifer LM, Sack M, Young GT. Capsaicin cream 0.025% as monotherapy for osteoarthritis: A double-blind study. Semin Arthritis Rheum 1994;23 Suppl 3:25-33. (Pubitemid 24209632)
30. Schnitzer T, Morton C, Coker S. Topical capsaicin therapy for osteoarthritis pain: Achieving a maintenance regimen. Semin Arthritis Rheum 1994;23 Suppl 3:34-40. (Pubitemid 24209633)
31. Schnitzer TJ, Posner M, Lawrence ID. High strength capsaicin cream for osteoarthritis pain: Rapid onset of action and improved efficacy with twice daily dosing. J Clin Rheumatol 1995;1:267-73.